What Global Institute for Disease Elimination does

The Global Institute for Disease Elimination (GLIDE) is a global health institute headquartered in Abu Dhabi, United Arab Emirates, founded in 2019. Its stated mission is to accelerate the elimination of preventable infectious diseases of poverty, with a programmatic frame that explicitly distinguishes elimination from disease control. The organization serves academic and public health research institutions, universities, and healthcare organizations focused on infectious disease elimination, with a primary geographic focus on the UAE and the wider MENA region.

GLIDE does not operate a commercial business model. It is funded through grants, institutional funding, and partnerships rather than product or service sales, and it has no documented products, services, pricing model, or technology platform. Its functional activities are collaborative research, training programs, internships, fellowships, and knowledge exchange between academic and public health institutions. The organization's most significant documented engagement is a March 2026 Memorandum of Understanding with United Arab Emirates University (UAEU), covering joint training programs, workshops, internships, fellowships, collaborative research funding applications, faculty and student engagement, mentorship, academic exchanges, data sharing, joint publications, and co-authored policy briefs. Leadership evidence is limited to Paul Hetherington, Director of Operations, Programs and Performance.

The institute's data footprint in the source material is sparse: no funding rounds, no headcount, no revenue figures, and no commercial customers are documented. A material operational signal worth flagging is that the organization's listed web domain, glide.ae, appears on a third-party domain marketplace as listed for sale, which warrants direct verification of current operational status before any investment conclusion is drawn.

Name

Global Institute for Disease Elimination

Website

https://glide.ae

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

GLIDE is an Abu Dhabi-based global health institute founded in 2019 that accelerates the elimination of preventable infectious diseases of poverty through collaborative research, training, fellowships, and partnerships with academic and public health institutions, primarily in the MENA region.

Ownership category

akta.pro rank

Product category

Public Health Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Humanitarian-Development-Peace Nexus & Resilience Programming (BPADAEAK)

Keywords

• Infectious disease elimination
• Public health research
• Global health training
• Disease control programs
• Health policy research

Headquarters

HQ city

Abu Dhabi

HQ country

United Arab Emirates

HQ region

Middle East

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Core offering

GLIDE is a global health institute that advances the elimination of preventable infectious diseases of poverty through collaborative research, training programs, workshops, internships, fellowships, and knowledge exchange with academic and public health institutions. The institute focuses on building local research expertise, supporting joint publications, and producing policy briefs to strengthen the role of the UAE and the broader MENA region in global health research.

Product overview

No product or service information available in the provided source data.

Differentiator

Problem solved

Functional benefit

Products and services

• Collaborative Disease Elimination Research
• Training Programs and Workshops
• Internships and Fellowships

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• United Arab Emirates University (UAEU)coreStrategic or Co-development Partner · 8 March 2026GLIDE and UAEU signed a Memorandum of Understanding in Abu Dhabi to strengthen collaboration on research, training, and knowledge exchange in infectious disease elimination and public health. The partnership establishes joint initiatives including training programs, workshops, internships, fellowships, and collaborative research funding applications, with emphasis on building local Emirati research expertise. The agreement includes faculty and student engagement through mentorship, academic exchanges, data sharing, joint publications, and co-authored policy briefs to advance the UAE's role in global health research.

Recent moves1 record

Expansion highlights3 records

Direct peers

• Drugs for Neglected Diseases Initiative (DNDi): Non-profit R&D organization focused on developing new treatments for neglected diseases of poverty; directly comparable to GLIDE in mission (disease elimination of poverty-related infectious diseases) and non-commercial, grant-funded operating model.
• Medicines for Malaria Venture (MMV): Product development partnership dedicated to reducing the burden of malaria, with explicit elimination framing; directly comparable to GLIDE in disease-elimination focus and donor-funded partnership model.
• END Fund: Private philanthropic fund dedicated to ending neglected tropical diseases (NTDs); comparable to GLIDE in targeting elimination (not just control) of poverty-related infectious diseases through partnership-driven funding.
• Task Force for Global Health: Non-profit focused on eliminating neglected tropical diseases and strengthening public health systems; directly comparable to GLIDE in disease-elimination mission and partnership-based delivery.
• Sabin Vaccine Institute: Non-profit working on vaccine development and NTD elimination with strong academic and institutional partnerships; directly comparable to GLIDE in mission, partnership model, and target disease set.
• FIND (Foundation for Innovative New Diagnostics): Global non-profit driving development and delivery of diagnostics for poverty-related diseases; directly comparable to GLIDE in mission, donor-funded model, and focus on infectious-disease elimination in low-resource settings.

Broad incumbents

• Coalition for Epidemic Preparedness Innovations (CEPI): Large, well-funded global partnership accelerating development of vaccines against epidemic threats; comparable as a broad incumbent in infectious-disease R&D, though with a much larger mandate and funding base than GLIDE.
• Wellcome Trust: Major global charitable foundation funding infectious-disease and public-health research; comparable as a large incumbent funder operating in the same disease-elimination space as GLIDE.
• Clinton Health Access Initiative (CHAI): Large global health organization working to strengthen health systems and expand access to treatment for HIV, malaria, and tuberculosis; comparable as a broad incumbent operating across the same disease-elimination agenda as GLIDE.

Regional players

• Global Health Innovative Technology Fund (GHIT Fund): Japan-based public-private partnership funding global health R&D for infectious diseases; comparable to GLIDE as a regionally-anchored, partnership-driven funder in the disease-elimination space, though with a different geographic anchor.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/glide_ae
• Facebookfacebook.com/GLIDEAE
• LinkedInlinkedin.com/company/glideae

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Institute for Disease Elimination